Posts by Christopher J. Stapleton, MD
Taurine May Predict Subarachnoid Hemorrhage Outcomes
Predicting aneurysmal subarachnoid hemorrhage is challenging due to the lack of a biometric marker. Using metabolomic profiling, Massachusetts General Hospital researchers identify taurine as a potential biomarker for predicting stroke in patients.
Recurrent Basilar Tip Pseudoaneurysm Treated Successfully with Flow Diversion
Neurosurgeons at Massachusetts General Hospital have reported the first case of an iatrogenic basilar aneurysm being successfully treated with a flow diverter.
How Blood Flow Diversion Can Treat Complex Ruptured Brain Aneurysms
A review by Mass General neurosurgeons explores concerns and controversies about flow diversion as an alternative to clipping or coiling for ruptured brain aneurysms.
Management of Cranial Cavernous Malformations Depends on Location and Symptoms
Cranial cavernous malformations (CMs) are the second most common type of central nervous system vascular lesion. Mass General neurosurgeons recently reviewed current data to help physicians identify CMs and make treatment plans.
Dr. Stapleton completed his neurosurgery residency and endovascular neurosurgery fellowship at Massachusetts General Hospital. He also completed an advanced cerebrovascular surgery fellowship at the University of Illinois at Chicago. His clinical specialization encompasses the evaluation and surgical and endovascular management of cerebral and spinal vascular pathologies, including arteriovenous malformations, brain aneurysms, carotid artery disease, cavernous malformations, cerebral hemorrhage, dural arteriovenous fistulae and ischemic stroke.